Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus.

Ooi ML, Drilling AJ, Morales S, Fong S, Moraitis S, Macias-Valle L, Vreugde S, Psaltis AJ, Wormald PJ.

JAMA Otolaryngol Head Neck Surg. 2019 Jun 20. doi: 10.1001/jamaoto.2019.1191. [Epub ahead of print]

PMID:
31219531
2.

Safety and efficacy of a bacteriophage cocktail in an in vivo model of Pseudomonas aeruginosa sinusitis.

Fong SA, Drilling AJ, Ooi ML, Paramasivan S, Finnie JW, Morales S, Psaltis AJ, Vreugde S, Wormald PJ.

Transl Res. 2019 Apr;206:41-56. doi: 10.1016/j.trsl.2018.12.002. Epub 2018 Dec 19.

PMID:
30615845
3.

In vitro characteristics of an airway barrier-disrupting factor secreted by Staphylococcus aureus.

Murphy J, Ramezanpour M, Drilling A, Roscioli E, Psaltis AJ, Wormald PJ, Vreugde S.

Int Forum Allergy Rhinol. 2019 Feb;9(2):187-196. doi: 10.1002/alr.22232. Epub 2018 Nov 15.

PMID:
30431711
4.

Staphylococcus aureus from patients with chronic rhinosinusitis show minimal genetic association between polyp and non-polyp phenotypes.

Bardy JJ, Sarovich DS, Price EP, Steinig E, Tong S, Drilling A, Ou J, Vreugde S, Wormald PJ, Psaltis AJ.

BMC Ear Nose Throat Disord. 2018 Oct 16;18:16. doi: 10.1186/s12901-018-0064-1. eCollection 2018.

5.

Safety and Efficacy of Topical Chitogel- Deferiprone-Gallium Protoporphyrin in Sheep Model.

Ooi ML, Richter K, Drilling AJ, Thomas N, Prestidge CA, James C, Moratti S, Vreugde S, Psaltis AJ, Wormald PJ.

Front Microbiol. 2018 May 11;9:917. doi: 10.3389/fmicb.2018.00917. eCollection 2018.

6.

Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients.

Fong SA, Drilling A, Morales S, Cornet ME, Woodworth BA, Fokkens WJ, Psaltis AJ, Vreugde S, Wormald PJ.

Front Cell Infect Microbiol. 2017 Sep 22;7:418. doi: 10.3389/fcimb.2017.00418. eCollection 2017.

7.

The persistence of intracellular Staphylococcus aureus in the sinuses: a longitudinal study.

Ou J, Bassiouni A, Drilling A, Psaltis AJ, Vreugde S, Wormald PJ.

Rhinology. 2017 Dec 1;55(4):305-311. doi: 10.4193/Rhin16.218.

PMID:
28687814
8.

Chitosan Dextran gel as an anti adhesion agent in a postlaminectomy spinal sheep model.

Rajiv S, Drilling A, Bassiouni A, Harding M, James C, Robinson S, Moratti S, Wormald PJ.

J Clin Neurosci. 2017 Jun;40:153-156. doi: 10.1016/j.jocn.2017.02.010. Epub 2017 Mar 11.

PMID:
28291642
9.

Long-Term Safety of Topical Bacteriophage Application to the Frontal Sinus Region.

Drilling AJ, Ooi ML, Miljkovic D, James C, Speck P, Vreugde S, Clark J, Wormald PJ.

Front Cell Infect Microbiol. 2017 Feb 24;7:49. doi: 10.3389/fcimb.2017.00049. eCollection 2017.

10.

Reduced Innate Immune Response to a Staphylococcus aureus Small Colony Variant Compared to Its Wild-Type Parent Strain.

Ou JJ, Drilling AJ, Cooksley C, Bassiouni A, Kidd SP, Psaltis AJ, Wormald PJ, Vreugde S.

Front Cell Infect Microbiol. 2016 Dec 26;6:187. doi: 10.3389/fcimb.2016.00187. eCollection 2016.

11.

Case Report: The Specter of Untreated Congenital Hypothyroidism in Immigrant Families.

Hamdoun E, Karachunski P, Nathan B, Fischer M, Torkelson JL, Drilling A, Petryk A.

Pediatrics. 2016 May;137(5). pii: e20153418. doi: 10.1542/peds.2015-3418. Epub 2016 Apr 14.

12.

Association of intracellular Staphylococcus aureus with prognosis in chronic rhinosinusitis.

Ou J, Drilling A, Singhal D, Tan NC, Wallis-Hill D, Vreugde S, Psaltis AJ, Wormald PJ.

Int Forum Allergy Rhinol. 2016 Aug;6(8):792-9. doi: 10.1002/alr.21758. Epub 2016 Apr 15.

PMID:
27080195
13.

Fighting sinus-derived Staphylococcus aureus biofilms in vitro with a bacteriophage-derived muralytic enzyme.

Drilling AJ, Cooksley C, Chan C, Wormald PJ, Vreugde S.

Int Forum Allergy Rhinol. 2016 Apr;6(4):349-55. doi: 10.1002/alr.21680. Epub 2015 Dec 17.

PMID:
26678532
14.

An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm-associated rhinosinusitis.

Jardeleza C, Thierry B, Rao S, Rajiv S, Drilling A, Miljkovic D, Paramasivan S, James C, Dong D, Thomas N, Vreugde S, Prestidge CA, Wormald PJ.

Transl Res. 2015 Dec;166(6):683-92. doi: 10.1016/j.trsl.2015.06.009. Epub 2015 Jun 24.

PMID:
26166254
15.

Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model.

Rajiv S, Drilling A, Bassiouni A, James C, Vreugde S, Wormald PJ.

Int Forum Allergy Rhinol. 2015 Apr;5(4):283-8. doi: 10.1002/alr.21459. Epub 2015 Jan 30.

PMID:
25643830
16.

Cousins, siblings, or copies: the genomics of recurrent Staphylococcus aureus infections in chronic rhinosinusitis.

Drilling A, Coombs GW, Tan HL, Pearson JC, Boase S, Psaltis A, Speck P, Vreugde S, Wormald PJ.

Int Forum Allergy Rhinol. 2014 Dec;4(12):953-60. doi: 10.1002/alr.21423. Epub 2014 Oct 1.

PMID:
25271410
17.

Small-colony variants and phenotype switching of intracellular Staphylococcus aureus in chronic rhinosinusitis.

Tan NC, Cooksley CM, Roscioli E, Drilling AJ, Douglas R, Wormald PJ, Vreugde S.

Allergy. 2014 Oct;69(10):1364-71. doi: 10.1111/all.12457. Epub 2014 Jul 29.

PMID:
24922342
18.

Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.

Drilling A, Morales S, Jardeleza C, Vreugde S, Speck P, Wormald PJ.

Am J Rhinol Allergy. 2014 Jan-Feb;28(1):3-11. doi: 10.2500/ajra.2014.28.4001.

PMID:
24717868
19.

Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis.

Drilling A, Morales S, Boase S, Jervis-Bardy J, James C, Jardeleza C, Tan NC, Cleland E, Speck P, Vreugde S, Wormald PJ.

Int Forum Allergy Rhinol. 2014 Mar;4(3):176-86. doi: 10.1002/alr.21270. Epub 2014 Jan 21.

PMID:
24449635
20.

Probiotic manipulation of the chronic rhinosinusitis microbiome.

Cleland EJ, Drilling A, Bassiouni A, James C, Vreugde S, Wormald PJ.

Int Forum Allergy Rhinol. 2014 Apr;4(4):309-14. doi: 10.1002/alr.21279. Epub 2014 Jan 10.

PMID:
24415658
21.

Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model.

Paramasivan S, Drilling AJ, Jardeleza C, Jervis-Bardy J, Vreugde S, Wormald PJ.

Int Forum Allergy Rhinol. 2014 Mar;4(3):187-95. doi: 10.1002/alr.21264. Epub 2014 Jan 10.

PMID:
24415444
22.

Inflammasome gene expression alterations in Staphylococcus aureus biofilm-associated chronic rhinosinusitis.

Jardeleza C, Miljkovic D, Baker L, Boase S, Tan NC, Koblar SA, Zalewski P, Rischmueller M, Lester S, Drilling A, Jones D, Tan LW, Wormald PJ, Vreugde S.

Rhinology. 2013 Dec;51(4):315-22. doi: 10.4193/Rhin13.045.

PMID:
24260763
23.

Is nasal steroid spray bottle contamination a potential issue in chronic rhinosinusitis?

Tan NC, Drilling AJ, Jardeleza C, Wormald PJ.

J Laryngol Otol. 2014 Jan;128 Suppl 1:S28-33. doi: 10.1017/S0022215113001229. Epub 2013 May 31.

PMID:
23722019
24.

The efficacy and safety of chitosan dextran gel in a burr hole neurosurgical sheep model.

Rajiv S, Harding M, Bassiouni A, Jardeleza C, Drilling A, James C, Ha T, Moratti S, Robinson S, Wormald PJ.

Acta Neurochir (Wien). 2013 Jul;155(7):1361-6; discussion 1366. doi: 10.1007/s00701-013-1767-0. Epub 2013 May 25.

PMID:
23709005

Supplemental Content

Loading ...
Support Center